These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3459509)

  • 21. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
    Coley HM; Amos WB; Twentyman PR; Workman P
    Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic drug penetration studies in multicellular tumour spheroids.
    Kerr DJ; Wheldon TE; Hydns S; Kaye SB
    Xenobiotica; 1988 Jun; 18(6):641-8. PubMed ID: 3166552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MST-16, a novel derivative of bis(2,6-dioxopiperazine), synergistically enhances the antitumor effects of anthracyclines.
    Inutsuka S; Baba H; Maehara Y; Sugimachi K
    Cancer Chemother Pharmacol; 1998; 42(3):194-200. PubMed ID: 9685054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I; Ohnoshi T; Hiraki S; Miyamoto H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
    Twentyman PR; Fox NE; Wright KA; Bleehen NM
    Br J Cancer; 1986 Apr; 53(4):529-37. PubMed ID: 3011054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of tumor growth inhibitory activity of macrophages exposed to adriamycin and adriamycin sensitivity of the target tumor cells.
    Giavazzi R; Bucana CD; Hart IR
    J Natl Cancer Inst; 1984 Aug; 73(2):447-55. PubMed ID: 6589436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
    Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
    Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells.
    Miyamoto H
    Acta Med Okayama; 1986 Apr; 40(2):75-81. PubMed ID: 3012966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N; Tapiero H; Sugimoto Y; Bungo M; Nishiyama M; Fourcade A; Lampidis TJ; Kasahara K; Sasaki Y; Takahashi T
    Cancer Res; 1990 Aug; 50(15):4698-701. PubMed ID: 2164445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1975 Apr; 31(4):417-23. PubMed ID: 1156523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.
    Chambers SH; Bleehen NM; Watson JV
    Br J Cancer; 1984 Mar; 49(3):301-6. PubMed ID: 6704304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory and apoptosis regulating effects of adriamycin on different human breast cancer cell lines].
    Yu ZY; Zuo WS; Wei L; Shan PY; Song XR; Liu YT; Liu YS; Zhou ZB; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):19-22. PubMed ID: 15808069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells.
    Ohnoshi T; Ohnuma T; Beranek JT; Holland JF
    J Natl Cancer Inst; 1985 Feb; 74(2):275-81. PubMed ID: 3856041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T
    Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
    Watanabe T; Naito M; Kokubu N; Tsuruo T
    J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D.
    Kurosawa K; Takahashi K; Tsuda E; Tomida A; Tsuruo T
    Jpn J Cancer Res; 2001 Nov; 92(11):1235-41. PubMed ID: 11714449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 40. Anthracyclines.
    Sinha BK; Politi PM
    Cancer Chemother Biol Response Modif; 1990; 11():45-57. PubMed ID: 2223402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.